SC

BEHAVIORAL4 trials

Sponsors

University of South Florida, Diabetes Care Center of Nanjing Military Command, Abramson Cancer Center at Penn Medicine, Klaus Ranta

Conditions

Adolescent - Emotional ProblemSmoking CessationSocial AnxietySocial Anxiety DisorderSubstance DependenceType 2 DiabetesWeight Loss

Phase 1

Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus

Diabetes Care Center of Nanjing Military CommandType 2 Diabetes

Start: 2013-10-31End: 2015-10-31Target: 100Updated: 2014-02-20

Phase 2

Distress Tolerance Treatment for Substance Users

University of South FloridaSubstance Dependence

Start: 2013-05-13End: 2019-09-01Target: 325Updated: 2018-10-11

Unknown Phase

Behavioral Activation for Smoking Cessation and the Prevention of Post-Cessation Weight Gain

CompletedNCT02906787

Abramson Cancer Center at Penn MedicineSmoking Cessation, Weight Loss

Start: 2016-09-13End: 2021-02-28Updated: 2024-05-29

School-based Treatment of Social Anxiety With Developmentally Oriented Cognitive Therapy for Social Anxiety Disorder

RecruitingNCT06489639

Klaus RantaAdolescent - Emotional Problem, Social Anxiety, Social Anxiety Disorder

Start: 2023-03-20End: 2028-12-31Target: 156Updated: 2024-07-08

Related Papers

Alternative model of personality disorders traits predict residential addictions treatment completion.

2021-09-018 citations

[The effect of liraglutide in combination with human umbilical cord mesenchymal stem cells treatment on glucose metabolism and β cell function in type 2 diabetes mellitus].

PubMed2016-05-0118 citations